Journal of Applied Phycology

, Volume 5, Issue 2, pp 235–241 | Cite as

Current knowledge on potential health benefits of Spirulina

  • Amha Belay
  • Yoshimichi Ota
  • Kazuyuki Miyakawa
  • Hidenori Shimamatsu


Spirulina is a microscopic filamentous alga that is rich in proteins, vitamins, essential amino acids, minerals and essential fatty acids like γ-linolenic acid (GLA). It is produced commercially and sold as a food supplement in health food stores around the world. Up to very recently, the interest in Spirulina was mainly in its nutritive value. Currently, however, numerous people are looking into the possible therapeutic effects of Spirulina. Many pre-clinical studies and a few clinical studies suggest several therapeutic effects ranging from reduction of cholesterol and cancer to enhancing the immune system, increasing intestinal lactobacilli, reducing nephrotoxicity by heavy metals and drugs and radiation protection. This paper presents a critical review of some published and unpublished data on therapeutic effects of Spirulina.

Key words

anti-virus hyperlipidemia immune system nephrotoxicity radioprotection Spirulina 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Archer DL, Glinsmann WH (1985) Intestinal infection and malnutrition initiate AIDS. Nutrition Research 5: 19.CrossRefGoogle Scholar
  2. Becker EW, Jakover B, Luft D, Schmuelling RM (1986) Clinical and biochemical evaluations of the alga Spirulina with regard to its application in the treatment of obesity: a double-blind cross-over study. Nutr. Rep. Int. 33: 565–574.Google Scholar
  3. Boudene C (1976) Evaluation of long term toxicity on rats with Spirulina. Ann. Nutr. Aliment. 30: 577–588.Google Scholar
  4. Cannell R, Owsianka AM, Walker JM (1988) Results of a large-scale screening programme to detect antibacterial activity from freshwater algae. Br. phycol. J. 23: 41–44.Google Scholar
  5. Chamorro-Cevalos G (1980) Toxicological research on the alga Spirulina. UNIDO, UF/MEX/78/048.Google Scholar
  6. Ciferri O, Tiboni O (1985) The biochemistry and industrial potential of Spirulina. Ann. Rev. Microbiol. 39: 503–526.CrossRefGoogle Scholar
  7. Dainippon Ink & Chemicals (DIC) (1983) Antitumoral agents containing phycobillin. Japanese Patent #58-65216, inventors: N. Iijima, N. Fujii & H. Shimamatsu; assignees: Dainippon Ink & Chemicals & Tokyo Stress Foundation, Apr. 18, 6 pp.Google Scholar
  8. Devi MA, Venkataraman LV (1983) Hypocholestemic effect of bluegreen algae Spirulina platensis in albino rats. Nutr. Rep. Int. 28: 519–530.Google Scholar
  9. Flores E, Wolk CP (1986) Production, by filamentous, nitrogen-fixing cyanobacteria, of a bacteriocin and of other antibiotics that kill related strains. Arch. Microbiol. 145: 215–219.PubMedCrossRefGoogle Scholar
  10. Fukino H, Takagi Y, Yamane Y (1990) Effect of Spirulina (S. platensis) on the renal toxicity induced by inorganic mercury and cisplatin. Eisei Kagaku 36: 5.Google Scholar
  11. Gustafson KR, Cardellina JH II, Fuller RW, Weislow OS, Kiser RF, Snader KM, Patterson GM, Boyd MR (1989) AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae). J. Natl. Cancer Inst. 81: 1254–1258.PubMedGoogle Scholar
  12. Hayashi O, Inaba Y, Matsunami K, Okuwaki Y, Kato T (1992) Paper presented at the 46th Annual Meeting of The Japanese Society of Nutrition and Food Science, Kurashiki, Japan.Google Scholar
  13. Hoppe HA, Levring T, Tanaka Y, (1979) Marine algae in pharmaceutical science. Walter de Gruyter, Berlin, 807 pp.Google Scholar
  14. Horrobin DF (1981a) The possible roles of prostaglandin E1 and of essential fatty acids in mannia, depression and alcoholism. Progr. Lipids 20: 539–541.CrossRefGoogle Scholar
  15. Horrobin DF (1981b) Loss of delta-6-desaturase activity as a key factor in aging. Med. Hypotheses 7: 1211–1220.PubMedCrossRefGoogle Scholar
  16. Horrobin DF, Huang YS (1983) Schizophrenia: the role of abnormal essential fatty acid and prostaglandin metabolism. Med. Hypotheses 10: 329–336.PubMedCrossRefGoogle Scholar
  17. Huang YS (1982) Most biological effects of zinc deficiency corrected by GLA. Atherosclerosis 41: 193–208.PubMedCrossRefGoogle Scholar
  18. Iwata K, Inayama T, Kato T (1987) Effects of Spirulina platensis on fructose-induced hyperlipidemia in rats. J. Jap. Soc. Nutr. Food Sci. 40: 463–467.Google Scholar
  19. Iwata K, Inayama T, Kato T (1990) Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr. Sci. Vitaminol. 36: 165–171.PubMedGoogle Scholar
  20. Jassby A (1988) Spirulina: a model for microalgae as human food. In Lembi C, Waaland JR (eds), Algae and Human Affairs. Cambridge University Press, 149–179.Google Scholar
  21. Johnson P, Shubert LE (1986) Availability of iron to rats from Spirulina, a blue-green alga. Nutr. Res. 6: 85–94.CrossRefGoogle Scholar
  22. Kataoka N, Misaki A (1983) Glycolipids isolated from Spirulina maxima: structure and fatty acid composition. Agric. Biol. Chem. 47: 2349–2355.Google Scholar
  23. Kato T, Takemoto K, Katayama H, Kuwabara Y (1984) Effects of Spirulina (Spirulina platensis) on dietary hypercholesterolemia in rats. J. Jap. Soc. Nutr. Food Sci. 37: 323–332.Google Scholar
  24. Kernoff PBA (1977) Antithrombotic potential of DGLA in man. Br. Med. J. 2: 1441–1444.PubMedCrossRefGoogle Scholar
  25. Kunkel SL (1982) Suppression of chronic inflamation by evening primrose oil. Progr. Lipids 20: 885–888.CrossRefGoogle Scholar
  26. Nagao K., Takai Y, Ono M (1991) Exercises of growing mice, and the effect of the intake of Spirulina platensis upon the hapten-specific immune response. Sci. Phys. Power 40: 187–194.Google Scholar
  27. Nakaya N, Honma Y, Goto Y (1988) Cholesterol lowering effect of Spirulina Nutr. Rep. Int. 37: 1329–1337.Google Scholar
  28. Noda H, Amano H, Arashima K, Hashimoto S, Nishizawa K (1989a) Studies on the antitumor activity of marine algae. Nippon Suisan Gakkaishi 55: 1259–1268.Google Scholar
  29. Noda H, Amano H, Arashima K, Hashimoto S, Nishizawa K (1989b) Antitumor activity of polysaccharides and lipids from marine algae. Nippon Suisan Gakkaishi 55: 1265–1271.Google Scholar
  30. Patterson GM, Baldwin CL, Bolis CM, Caplan FR, Karuso H, Larsen LK, Levine IA, Moore RE, Nelson CS, Tschappat KD, Tuang GD, Furusawa E, Furusawa S, Norton TR, Raybcurne RB (1991) Antineoplastic activity of cultured blue-green algae (Cyanophyta). J. Phycol. 27: 530–536.CrossRefGoogle Scholar
  31. Peto R (1981) Can dietary beta carotene materially reduce human cancer rates? Nature 290: 201–208.PubMedCrossRefGoogle Scholar
  32. Qishen P, Coleman A, Baojiang G (1989) Radioprotective effect of extract from Spirulina platensis in mouse bone marrow cells studied by using the micronucleus test. Toxicology Lett. 48: 165–169.CrossRefGoogle Scholar
  33. Schwartz JL, Sklar G (1987) Regression of experimental hamster cancer by beta carotene and algae extracts. J; Oral Maxillorfac. Surg. 45: 510–515.CrossRefGoogle Scholar
  34. Schwartz JL, Sklar G, Reid S, Trickler D (1988) Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae. Nutr. Cancer 11: 127–134.PubMedCrossRefGoogle Scholar
  35. Shekelle RB (1981) Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 8257: 1185–1189.CrossRefGoogle Scholar
  36. Takai Y, Hosoyamada Y, Kato T (1991) Effect of water-soluble and water insoluble fractions of Spirulina over serum lipids and glucose resistance of rats. J. Jap. Soc. Nutr Food Sci. 44: 273–277.Google Scholar
  37. Tsuchihashi N, Watanabe T, Takai Y (1987) Effect of Spirulina platensis on caecum content in rats. Bull. Chiba Hygiene College, Chiba, Japa,. 5: 27–30.Google Scholar
  38. Tudge C (1981) Why we could all need the evening primrose. New Scientist 506: 23.Google Scholar
  39. Vadaddi KS, Horrobin DF (1979) Weight loss produced by evening primrose oil administration. IRSC Med. Sci. 7: 52.Google Scholar
  40. Venkataraman LV, Becker EW (1985) Biotechnology and utilization of algae-The Indian experience. Sharada Press, Mangalore, India, 114–115.Google Scholar
  41. Yamane Y, Fukino H, Icho T, Kato T, Shimamatsu H (1988) Effect of Spirulina (Spirulina platensis) on the renal toxicity induced by inorganic mercury and para-aminophenol. Summary of Abstracts: 108th Annual Conference of the Pharmaceutical Society of Japan, p. 58.Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Amha Belay
    • 1
  • Yoshimichi Ota
    • 1
  • Kazuyuki Miyakawa
    • 2
  • Hidenori Shimamatsu
    • 2
  1. 1.Earthrise FarmsCalipatriaUSA
  2. 2.Dainippon Ink & Chemicals Inc., Biochemical Division 7-20, Nihonbashi 3-ChomeTokyoJapan

Personalised recommendations